353 related articles for article (PubMed ID: 35729778)
1. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
Nguyen NHA; Falagan-Lotsch P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
[TBL] [Abstract][Full Text] [Related]
3. Nanotoxicology and Nanomedicine: The Yin and Yang of Nano-Bio Interactions for the New Decade.
Bondarenko O; Mortimer M; Kahru A; Feliu N; Javed I; Kakinen A; Lin S; Xia T; Song Y; Davis TP; Lynch I; Parak WJ; Leong DT; Ke PC; Chen C; Zhao Y
Nano Today; 2021 Aug; 39():. PubMed ID: 36937379
[TBL] [Abstract][Full Text] [Related]
4. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects.
Zhang P; Xiao Y; Sun X; Lin X; Koo S; Yaremenko AV; Qin D; Kong N; Farokhzad OC; Tao W
Med; 2023 Mar; 4(3):147-167. PubMed ID: 36549297
[TBL] [Abstract][Full Text] [Related]
5. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
6. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
Patel P; Shah J
Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
10. Bridging Bio-Nano Science and Cancer Nanomedicine.
Björnmalm M; Thurecht KJ; Michael M; Scott AM; Caruso F
ACS Nano; 2017 Oct; 11(10):9594-9613. PubMed ID: 28926225
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
12. Current landscape of treating different cancers using nanomedicines: Trends and perspectives.
Morales CS; Grodzinski P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1927. PubMed ID: 37706362
[TBL] [Abstract][Full Text] [Related]
13. Engineered Nanomaterials: The Challenges and Opportunities for Nanomedicines.
Albalawi F; Hussein MZ; Fakurazi S; Masarudin MJ
Int J Nanomedicine; 2021; 16():161-184. PubMed ID: 33447033
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicines accessible in the market for clinical interventions.
Gadekar V; Borade Y; Kannaujia S; Rajpoot K; Anup N; Tambe V; Kalia K; Tekade RK
J Control Release; 2021 Feb; 330():372-397. PubMed ID: 33370576
[TBL] [Abstract][Full Text] [Related]
15. Delivering the power of nanomedicine to patients today.
Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R
J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950
[TBL] [Abstract][Full Text] [Related]
16. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
17. Development of Nanomedicines and Nano-Similars: Recent Advances in Regulatory Landscape.
Paliwal R; Kumar P; Chaurasiya A; Kenwat R; Katke S; Paliwal SR
Curr Pharm Des; 2022; 28(2):165-177. PubMed ID: 34781869
[TBL] [Abstract][Full Text] [Related]
18. Toxicologic Concerns with Current Medical Nanoparticles.
Cheng TM; Chu HY; Huang HM; Li ZL; Chen CY; Shih YJ; Whang-Peng J; Cheng RH; Mo JK; Lin HY; Wang K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886945
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology in Drug Delivery: Safety and Toxicity Issues.
Jain K; Mehra NK; Jain NK
Curr Pharm Des; 2015; 21(29):4252-61. PubMed ID: 26323425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
